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Abstract:
Regulation of maturation in meiotically competent mammalian oocytes is a
complex process involving the carefully coordinated exchange of signals
between the somatic and germ cell compartments of the ovarian follicle via
paracrine and cell-cell coupling pathways. This review highlights recent
advances in our understanding of how such signaling controls both meiotic
arrest and gonadotropin-triggered meiotic resumption in competent oocytes
and relates them to the historical context. Emphasis will be on rodent
systems, where many of these new findings have taken place. A regulatory
scheme is then proposed that integrates this information into an overall
framework for meiotic regulation that demonstrates the complex interplay
between different follicular compartments.

I. Overview of Oocyte Maturation
Meiosis is initiated in the mammalian oocyte during fetal
development but at about the time of birth becomes arrested late in
prophase I, at the late G2 phase of the cell cycle, and can persist in
this state for many years. When a cohort of follicles is stimulated to
initiate development, meiotic arrest is maintained throughout the
period of oocyte and follicle growth, during which time the oocyte
achieves competence to undergo meiosis (Fig. 1). Follicle and oocyte
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development is orchestrated by a bidirectional exchange of signals
between the germ and somatic cell compartments; paracrine oocyte
signals direct the differentiation of the mural and cumulus granulosa
cells and their regulation of germ cell developmental competence
(Gilchrist and Thompson, 2007; Su et al, 2009). Meiotically competent
oocytes within Graafian follicles will then resume meiotic maturation in
response to the preovulatory surge of gonadotropins, a response
brought about, at least in part, by the generation of a transient spike
in cAMP levels within the granulosa cells.

Figure 1

Overview of oocyte maturation. The oocyte remains meiotically

incompetent and in prophase I arrest during the period of follicular and oocyte growth.
At the time of meiotic resumption the nucleus, or germinal vesicle, breaks down as the
chromosomes condense and meiosis proceeds until the metaphase II stage that
immediately follows extrusion of the first polar body. The MII arrest is maintained in
healthy oocytes until successful fertilization is achieved, whereupon the oocyte
completes maturation, maternal and paternal chromatin is combined, and embryonic
development is initiated.

If oocytes are removed from non-stimulated Graafian follicles
and placed in a suitable culture medium, they will undergo
spontaneous, hormone-independent nuclear maturation, indicated by
germinal vesicle breakdown (GVB), the first easily observed
manifestation of maturation (Pincus and Enzmann, 1934; Edwards,
1965). The G2-to-M phase cell cycle progression, which occurs at the
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time of GVB in oocytes, depends on the activation of maturation
promoting factor (MPF), a dimer comprised of CDK kinase and cyclin B
subunits (Norbury and Nurse, 1992). MPF activation leads to a cascade
of cellular phosphorylation through serine/threonine kinase activity
(Murray and Kirschner, 1989), driving chromosome condensation and
dissolution of the nuclear envelope. MPF activity is negatively
controlled by cAMP through regulation of Wee1 kinases and cdc25
phosphatases (Han et al, 2005; Han and Conti, 2006; Solc et al, 2008;
Zhang et al, 2008; Pirino et al, 2009).
Because of the phenomenon of spontaneous maturation, it is
evident that the somatic compartment of the ovarian follicle imposes
an inhibitory constraint upon the oocyte, maintaining it in meiotic
arrest, and this meiotic arrest can be achieved in vitro in isolated
oocytes by a number of inhibitory agents, including cAMP analogs,
purines and phosphodiesterase inhibitors (Schultz, 1986), that block
the activation of MPF (Choi et al, 1991). However, under these
inhibitory conditions, addition of gonadotropin or other suitable ligand
leads to the induction of GVB, but only in oocytes enclosed by
granulosa cells (Downs et al, 1988). Thus, within the follicle, the
somatic compartment controls both the maintenance of meiotic arrest
and induction of meiotic resumption.
Once GVB has been triggered, the oocyte progresses meiotically
through metaphase I (MI) and reaches metaphase II (MII), where it
arrests for a second time. This second arrest point occurs at about the
time of ovulation and is controlled by the oocyte itself, since by this
time close association of the somatic and germ cell compartments has
been eliminated through mucification and expansion of the cumulus
granulosa cells. No further development is possible unless the oocyte
is fertilized or activated parthenogenetically.
This review will focus on aspects of meiotic regulation
surrounding the prophase I block, including maintenance of meiotic
arrest and possible mechanisms of meiotic induction. Emphasis will be
on studies using rodent oocytes, since many recent advances in our
understanding of meiosis have occurred in these species. Other useful
reviews on oocyte maturation include Zhang et al, 2009; Hsieh et al,
2009; Tsafriri and Motola, 2007; Lefevre et al, 2007; Kimura et al,
2007; Mehlmann, 2005; Tsafriri et al, 2005; Dekel, 2005).
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II. In Vitro Models for Studying Mammalian
Oocyte Maturation
Illustrated in Fig. 2 are three different in vitro models commonly
utilized to study oocyte maturation. There are pros and cons to each of
these approaches, but information gleaned from all three has proven
useful in delineating different aspects of meiotic regulation. The first is
the most physiological and involves dissecting out intact preovulatory
follicles. Because the follicle is intact, meiotic arrest is maintained
naturally in culture without the need for supplementary inhibitors.
Meiotic resumption can then be stimulated with gonadotropins or other
agents such as EGF-like peptides. The second model system utilizes
cumulus cell-enclosed oocytes (CEO) isolated from preovulatory
follicles. Due to the reduced number of follicle cells, meiosis-inhibitory
capability is lost, and these oocytes will undergo spontaneous
maturation in vitro unless a meiotic inhibitor, such as a cAMP analog or
phosphodiesterase inhibitor, is added to the medium. Under inhibitory
conditions, meiotic resumption can be induced by gonadotropin or
other stimulatory ligands. In the last system, the cumulus cells are
removed to produce denuded oocytes (DO). DO will also undergo
spontaneous maturation unless meiotic inhibitors are added, but,
unlike CEO, will not respond to hormonal stimulation due to the
absence of mediating follicle cells that possess the necessary
receptors.
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Figure 2

In vitro model systems for studying oocyte maturation. The intact

preovulatory follicle (top) maintains the oocyte in the germinal vesicle (GV) stage in
the absence of hormonal stimulation. The addition of hormone (gonadotropins or EGFlike peptides) stimulates germinal vesicle breakdown (GVB) after binding to receptors
on the follicle cells. Arrows show the cells responsive to each of the hormones.
Removal of the cumulus-enclosed oocyte (CEO) results in spontaneous maturation in
the absence of added inhibitor. If maintained in meiotic arrest with appropriate
inhibitor, GVB can be induced by proper hormonal stimulation (FSH and EGF-like
peptides, but not LH). Removal of cumulus cells produces a denuded oocyte (DO) that
will also undergo spontaneous maturation, but is unresponsive to hormones if
maintained in meiotic arrest.

It is important to understand the limitations of these different
experimental approaches. While the study of isolated DO and CEO
enables the examination of direct effects of certain agents on these
target cells without the confounding influence of additional follicular
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tissue, the system is not completely physiological. On the other hand,
it is sometimes difficult when using the more complex cultured follicle
system or intact animal to identify the specific tissue(s) targeted by a
particular treatment that mediate a meiotic response. Also, the
literature is replete with studies demonstrating that the spontaneous
meiotic maturation occurring when oocytes are removed from the
follicle and cultured in permissive medium is not under the same
regulation as oocytes induced to resume maturation by hormonal
stimulation. Thus, one must be cautious when using the spontaneous
maturation model, since some of the oocyte behaviors may not
duplicate those elicited by meiosis-inducing stimuli in the intact follicle.

III. Maintenance of Meiotic Arrest
Folliculogenesis involves a close cooperative association
between the developing germ and somatic cells. Bidirectional signaling
between these two compartments ensures the proper differentiation of
each cell type and successful development of the preovulatory follicle.
This is exemplified by recent studies showing that, under the direction
of oocyte-secreted factors, the surrounding cumulus granulosa cells
carry out critical metabolic functions that the oocyte is unable to
perform (Su et al, 2009). Granulosa cell products can then reach the
oocyte by paracrine means or by direct transfer between the
heterologous cells. During follicle growth, the oocyte is intimately
coupled to the surrounding granulosa cells by gap junctional
communication, enabling transmission of ions and small molecules
through these intercellular membrane channels. Connexin (Cx)
proteins are the fundamental units of gap junctions that provide for
granulosa-granulosa coupling as well as granulosa-oocyte coupling.
Cx43 is a major connexin present in gap junctions between somatic
cells, while Cx37 junctions are restricted to the granulosa-oocyte
interface (Kidder and Mhawi, 2002; Teilmann, 2005; see Fig. 2). While
some Cx37 is expressed in granulosa cells away from the oocyte
interface, homotypic Cx37 junctions exist primarily at this interface
where they are controlled by the oocyte and mediate coupling between
the two cell types (Veitch et al, 2004; see Fig. 3). The importance of
these gap junctional proteins in folliculogenesis has been
demonstrated by failure of normal development following knockout of
either connexin in mice, with loss of Cx43 function severely restricting
folliculogenesis (Juneja et al, 1999), while ablation of Cx37 function
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prevents both follicular development to the antral stage as well as
normal oocyte growth and acquisition of meiotic competence (Simon et
al, 1997; Carabatsos et al, 2000). Cx37 is probably responsible for
mediating meiotic control in mice, since normal oogenesis occurred
upon oocyte-targeted depletion of Cx43 (Gershon et al, 2008).

Figure 3

Gap junction regulation of meiotic status. Homologous Cx 43 gap

junctions couple mural granulosa cells (green) to one another and cumulus granulosa
cells (blue) to one another, and heterologous gap junctions couple mural granulosa
cells to cumulus granulosa cells. Heterologous Cx 37 gap junctions in the innermost
layer of cumulus cells couple the somatic compartment of the follicle to the oocyte.
Two different models exist for meiotic regulation. In the loss of inhibition model, loss
of Cx 43 coupling terminates the flux of inhibitor (cAMP and cGMP) from mural to
cumulus cells, thereby significantly reducing levels within the oocyte and leading to
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GVB. In the positive stimulation model, patent gap junctions mediate the flux of a
positive stimulus into the oocyte from the surrounding follicle cells that can override
elevated cyclic nucleotide levels, although contribution of a diffusible paracrine factor
(dotted lines) originating from the granulosa cells cannot be discounted.

cAMP involvement
cAMP is an important physiological regulator of meiosis that
maintains meiotic arrest by suppressing MPF activity through
stimulation of cAMP-dependent protein kinase A (PKA). Many studies
have confirmed that adenylate cyclase activators, cAMP analogs or
phosphodiesterase (PDE) inhibitors reversibly suppress GVB and that
inhibitors or antagonists of PKA can reverse meiotic arrest maintained
by cAMP-elevating agents (Schultz, 1991). In addition, perturbation of
PKA activity by knockdown of the type I regulatory subunit promoted
oocyte maturation (Duncan et al, 2006). Moreover, a decrease in
oocyte cAMP has been shown to precede GVB (Schultz et al, 1983,
Vivarelli et al, 1983; Racowsky, 1984; Dekel et al, 1984; Sirard and
First, 1988). Evidence has shown that stimulation of cAMP production
in the granulosa cells can drive diffusion of the cyclic nucleotide into
the oocyte via the gap junctional pathway (Bornslaeger and Schultz,
1985a; Webb et al, 2002). Consistent with this phenomenon is the
proposal that granulosa cells maintain the oocyte in prophase I in vivo
by supplying meiosis-arresting levels of cAMP through this coupling
pathway (Gilula et al, 1978; Dekel et al, 1981).
Alternatively, substances may diffuse into the oocyte from the
extracellular milieu that could impart an inhibitory influence to the
oocyte, helping to maintain cAMP at meiosis-arresting levels. Once
such compound is the purine base, hypoxanthine, a weak inhibitor of
cAMP degradation (Downs et al, 1989) that was originally identified in
porcine follicular fluid (Downs et al, 1985) and was subsequently
measured in mouse follicular fluid at levels that maintain meiotic arrest
(Eppig et al, 1985), though its efficacy is strain-dependent (Griffin et
al, 2004). However, it is doubtful that hypoxanthine is the primary
intrafollicular inhibitor responsible for maintaining meiotic arrest in situ
due to its limited inhibitory potency; in fact, it may be released within
the follicle as a consequence of follicular hypoxia. Nevertheless, its
presence within the follicle implies potential participation in the overall
negative regulation of meiosis, and, consequently, it has often been
used in culture media to maintain meiotic arrest in vitro. Moreover, its
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inhibitory potential has been confirmed in numerous mammalian
species (Downs, 1996).
The idea that oocyte cAMP derives primarily from the granulosa
cells was challenged by the finding that treatment of DO with the
adenylate cyclase stimulator, forskolin, elicits suppression of
spontaneous maturation in vitro in several rodent species in concert
with an elevation in oocyte cAMP (Urner et al, 1983; Olsiewski and
Beers, 1983; Ekholm et al, 1984; Racowsky, 1984, 1985). Though
denudation of oocytes can leave remnants of the cumulus cells still
attached to the oocyte (Eppig and Downs, 1984), Bornslaeger and
Schultz (1985b) showed that enzymatic removal of the zona pellucida
and most of the somatic cell processes produced an oocyte still
capable of cAMP generation in response to forskolin, thus confirming
an oocyte source of cAMP. Further evidence supporting oocyte-derived
cAMP came from studies showing a transient delay in spontaneous
maturation upon treatment of oocytes with nonhydrolyzable GTP
analogs (Downs et al, 1992) or the Gs activator, cholera toxin (Dekel
and Beers, 1978; Schultz et al, 1983b; Vivarelli et al, 1983; Downs et
al, 1992), which suggested a G-protein-mediated mechanism, and in
immunocytochemical localization of adenylate cyclase at the oolemma
(Kuyt et al, 1988). Moreover, in the intact oocyte-cumulus cell
complex, elevation of cAMP within the cumulus cells does not always
lead to equilibration of cyclic nucleotide with the oocyte despite a
patent coupling pathway (Schultz et al, 1983; Bilodeau et al, 1993).
Definitive evidence for an oocyte source of cAMP came from a
study showing that both mouse and rat oocytes express the functional
AC3 isoform of adenylate cyclase; in addition, mice lacking this
isoform exhibited compromised meiotic arrest in vivo and accelerated
spontaneous maturation in vitro (Horner et al, 2003). Using an intact
mouse follicle system whereby injections could be directed into the
oocyte, Mehlmann, Jaffe and colleagues showed that meiotic arrest
could be interrupted by microinjection of antibodies to, or a dominant
negative form of, Gs, demonstrating the presence of a G-protein-linked
receptor at the oolemma (Mehlmann et al, 2002; Kalinowski et al,
2004). Subsequent studies determined that oocyte expression of the
G-protein coupled receptor, PGR3, is essential for maintaining cAMP
levels and meiotic arrest (Mehlmann et al, 2004; Hinckley et al, 2005;
Ledent et al, 2005). GPR3 exhibits constitutive activity that is
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independent of granulosa cell influence (Freudzon et al, 2005). An
additional functional receptor, GPR12, was also identified in both rat
and mouse oocytes (Hinckley et al, 2005), but seems to be important
only in the rat, since the knockout mouse exhibited no phenotype.
Maintenance of cyclic nucleotide levels in cells is maintained by
a balance between synthesis, degradation and release from the cell.
Major players in determining cyclic nucleotide concentration are the
cyclic nucleotide phosphodiesterases (PDEs), a diverse group of
enzymes that hydrolyze the 3′ phosphate bond of cyclic nucleotides.
For example, in the human genome, twenty-one PDE-encoding genes
and their corresponding proteins have been identified and
characterized, with some specific for cAMP, some specific for cGMP,
and others that recognize both cyclic nucleotides (Conti and Beavo,
2007). PDEs specific for cAMP show an interesting
compartmentalization within the mammalian follicle. Milrinone and
cilostamide, inhibitors of PDE3-specific isoforms, suppress
spontaneous oocyte maturation in follicle-enclosed rat oocytes, but the
PDE4-specific inhibitor, rolipram, has little effect even at very high
concentrations; on the other hand, rolipram alone, but not PDE3
inhibitors, stimulates GVB in cultured follicles (Tsafriri et al, 1996).
These results suggested that PDE3 resides in the oocyte, while PDE4 is
present in the somatic compartment, and this was confirmed by in situ
hybridization. Similar results have been reported from numerous
laboratories (eg, Shitsukawa et al, 2001; Jensen et al, 2002; Mayes
and Sirard, 2002; Nogueira et al, 2003; Thomas et al, 2004; Laforest
et al, 2005). In 1998, Wiersma et al reported the exciting finding that
injection of PDE3 inhibitors into superovulated rats and mice prevented
meiotic resumption without affecting ovulation rate, strongly
suggesting an essential need for oocyte PDE3 in mediating meiotic
resumption via cAMP degradation. Indeed, PDE3A activity was shown
to increase after gonadotropin stimulation prior to GVB (Richard et al,
2001). An absolute requirement for this PDE isoform was later proven
when the same lab showed PDE3A-deficient mice were infertile due to
an inability of the oocytes to resume maturation (Masciarelli et al,
2004).
Similar to the results with PDE isoforms, we reported differential
regulation of PKA isozymes within the germ and somatic cell
compartments of oocyte-cumulus cell complexes from mice (Downs
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and Hunzicker-Dunn, 1995). Only the type I regulatory PKA subunit
was detected in oocytes by photoaffinity labeling of PKA regulatory
subunits with 8-N3-[32P]cAMP, while both type I and II isoforms were
identified in cumulus cells. In addition, by the use of site-selective
analogs of cAMP, that in various combinations can selectively activate
type I or II PKA, meiotic arrest was shown to be more pronounced in
type I PKA-stimulated oocytes, while selective activation of type II PKA
in oocyte-cumulus cell complexes more effectively promoted oocyte
maturation and cumulus expansion. It was concluded that type I PKA
in the oocyte mediates meiotic arrest, while type II PKA in the
granulosa cells mediates maturation of the oocyte-cumulus cell
complex. Similar conclusions were drawn from studies by Rodriguez et
al (2002). However, more recent reports have demonstrated the
presence of both type I and II regulatory PKA isoforms in mouse
oocytes (Brown et al, 2002; Newhall et al, 2006), and in one of these
studies (Newhall et al, 2006) a combination of site-selective cAMP
analogs that preferentially stimulate type II PKA isoforms were
presented as more potent in maintaining meiotic arrest when
compared with a combination that selectively activated type I PKA,
with the conclusion that type II PKA is the more relevant isoform
performing this function. Nevertheless, this conclusion seems tenuous,
since only one site-selective pairing was compared, and the dose
response curves were nearly superimposable. It therefore seems safer
to propose that activation of either isoform in the oocyte can suppress
GVB.
Subcellular compartmentalization of PKA isozymes within the
oocyte is facilitated by A-kinase anchoring proteins (AKAPs). AKAPs
serve as scaffolding proteins that bind to PKAs and regulate their
cellular localization, forming microdomains of phosphorylation
signaling (Wong and Scott, 2004; Smith et al, 2006). AKAPs have
been identified in rodent oocytes, and their localization is
developmentally regulated (Brown et al, 2002; Kovo et al, 2002;
Newhall et al, 2006; Webb et al, 2008). More significantly, disruption
of AKAP-mediated anchoring of PKA by treatment with peptide
inhibitors reverses meiotic arrest maintained by PDE inhibitor (Dekel,
2005; Newhall et al, 2006), demonstrating a vital role for AKAPs in
meiotic arrest. However, AKAP1-null oocytes are more sensitive to the
meiosis-arresting action of cAMP-elevating agents than wild type
oocytes (Newhall et al, 2006), signifying the involvement of multiple
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AKAPs in meiotic regulation. Controlling PKA localization within the
oocyte via AKAPs might help explain how meiotic resumption can be
induced in the presence of elevated cAMP.

Control of MPF activity
Ample pre-MPF (Cdk1 and cyclin B) exists in the meiotically
competent mouse oocyte, and its activity is controlled by the
phosphorylation state of Cdk1. Sustained levels of cAMP in the mouse
oocyte persistently activate PKA, promoting phosphorylations that
positively regulate Wee1 kinase (Han et al, 2005), and negatively
regulate Cdc25B phosphatase (Lincoln et al, 2005; Pirino et al, 2009).
These PKA substrates control MPF activity at two highly conserved
phosphorylation sites (Thr14 and Tyr15) on the Cdk1 kinase of MPF;
phosphorylation by the Wee1 family of kinases (Wee 1B and Myt1)
inactivates the kinase, while dephosphorylation by the Cdc25 family,
most notably Cdc25B, promotes activation (Fig. 4A). Thus, the control
of MPF by PKA is indirect, brought about by phosphorylation of
mediating proteins.
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Figure 4

Regulation of MPF activity in the mouse oocyte. A, Control of MPF by PKA.

MPF activity is regulated by the phosphorylation state of the Cdk1 subunit. PKA
activity is dependent on cAMP levels. This cyclic nucleotide binds to the regulatory
subunit (PKAR), driving dissociation from, and activation of, the catalytic subunit
(PKAC; asterisk denotes activated state). When sufficient cyclin B is present, MPF is
maintained in the inactive state by the action of Wee1 and Myt1 kinases that are
positively regulated by PKA. Dephosphorylation of Cdk1 triggers activation of MPF and
is principally driven by Cdc25B that is negatively regulated by PKA. This response
occurs when PKA activity is lowered by a decrease in cAMP, brought about by the
action of PDE3. Increased PDE3 activity results from a drop in cGMP levels or active
stimulation by Akt or perhaps PKA. B, Effect of Myt1/Wee1/Cdc25B localization on MPF
activity. In the competent oocyte, pre-MPF accumulates in the nucleus. Under meiosisarresting conditions, Wee1B is present in the germinal vesicle, but Myt1 and Cdc25B
are restricted to the cytoplasm, and this is under PKA control. When oocyte cAMP
levels are reduced, Wee1B exits the nucleus and Cdc25B translocates into the nucleus.
The loss of inhibitory Wee1B and the entry of stimulatory Cdc25B promotes
dephosphorylation of pre-MPF in the germinal vesicle and its subsequent activation
that will drive GVB.
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Localization of these regulatory proteins within the mouse
oocyte plays a vital role in controlling MPF activity. During the
development of meiotic competence in mouse oocytes, the
components of MPF, Cdk1 and cyclin B, accumulate in the nucleus,
where they will direct meiotic resumption (Mitra and Schultz, 1996).
Indeed, meiotic regulation is significantly affected by the nuclear
abundance of cyclin B (Marangos and Carroll, 2004). Zhang et al
(2008) showed that phosphorylation of Cdc25B by PKA sequesters it in
the cytoplasm, while a decrease in oocyte cAMP that drives
inactivation of PKA leads to translocation of Cdc25B from the
cytoplasm into the nucleus, activation of MPF and meiotic resumption
(Fig. 4B). A recent study by Oh et al, (2010) confirms this mechanism
and further clarifies contributions from Wee1B and Myt1 kinases. In
the prophase I-arrested mouse oocyte, Wee1B is confined to the
nucleus, while Myt1 and Cdc25B are present only in the cytoplasm.
Under conditions that permit meiotic resumption, prior to germinal
vesicle breakdown Cdc25B initially translocates to the nucleus,
subsequently followed by the exodus of a significant fraction of Wee1B
from the nucleus into the cytoplasm. The localization of Myt1 is not
affected before meiotic resumption (Fig. 4B). All three components are
required for optimal regulation of MPF activity, and it appears that
removal from the nucleus of the inhibitory kinase combined with entry
of the stimulatory phosphatase converts pre-MPF to active meiotic
inducer (Oh et al, 2010; Fig. 3B). A similar role for cdc25C has been
reported in human oocytes (Cunat et al, 2008).
Additional MPF regulation exists at the level of the anaphasepromoting complex (APC). Destruction of cyclin B inactivates MPF and
requires polyubiquitination by the APC that targets it for proteosomal
degradation (Murray, 2004). Reis et al (2006) demonstrated that
cyclin B levels in mouse oocytes are restricted by the activity of APC
that is maintained by the activator, cdh1. Germinal vesicle-stage
oocytes contain active APC that is down-regulated by cdh1-targeted
morpholinos, leading to reduced cyclin B degradation and promotion of
meiotic resumption in milrinone-arrested oocytes. Further evidence for
APC mediation of meiotic arrest was provided by Marangos et al
(2007), who showed that depletion of the APC inhibitor, Emi1, delays
entry of mouse oocytes into meiosis I and that microinjection of Emi1
accelerated meiotic resumption. In addition, inhibition of proteosome
activity induces GVB in hypoxanthine-arrested mouse oocytes in vitro
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(Huo et al, 2004). Evidence also indicates that APC regulates
reinitiation of meiosis in pig oocytes (Yamamuro et al, 2008).

cGMP involvement
Because the predominant PDE in oocytes controlling cAMP levels
is cGMP-regulated PDE3A (Shitsukawa et al, 2001), a primary
candidate for the physiological modulator of PDE3A activity is cGMP.
This cyclic nucleotide has a myriad of functions in the mammalian
ovary (reviewed by LaPolt et al, 2003). About three decades ago it was
shown that ovarian cGMP levels decline significantly in rat (Ratner,
1976; Ratner and Sanborn, 1980) and hamster (Makris and Ryan,
1978; Hubbard, 1980) ovaries following LH stimulation. In addition, an
inverse relationship exists between cAMP and cGMP levels (Hubbard,
1980). Exposure of hamster oocytes to the cGMP analog, 8-Br-cGMP,
proved inhibitory to spontaneous maturation in cumulus cell-enclosed
oocytes (CEO) but not denuded oocytes (DO), and this effect was
reversed by LH treatment (Hubbard and Terranova, 1980). The
authors raised several important points regarding a potential role for
cGMP in meiotic regulation: (1) general PDE inhibitors such as IBMX
may suppress maturation by their action on cGMP as well as cAMP; (2)
cGMP action depends on the cumulus cells and may involve alterations
in cell-cell coupling; and (3) LH may trigger meiosis reinitiation by
lowering somatic cell cGMP levels.
A role for cGMP was further supported by work from other
laboratories that demonstrated an inhibitory effect of cGMP analogs
and cGMP PDE-specific inhibitors on oocyte maturation in several
mammalian species (Downs et al, 1988; Tornell et al, 1991; Zhang et
al, 2005; Wang et al, 2008) and a drop in oocyte cGMP levels prior to
GVB (Tornell et al, 1990). In addition, blocking the flow of purine
metabolism to guanyl compounds at the inosine monophosphate
branchpoint with IMP dehydrogenase inhibitors, which would prevent
the formation of GTP and, presumably, cGMP, induces meiotic
resumption in mouse oocytes both in vivo (Downs and Eppig, 1997)
and in vitro (Downs et al, 1986; Downs, 1990). The fact that these
inhibitors trigger GVB in CEO but not DO is consistent with the idea
that guanyl compounds such as cGMP are produced in the somatic
compartment and then diffuse to the oocyte to contribute to meiotic
arrest. Indeed, treatment of rat follicles with an inhibitor of soluble
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guanylate cyclase triggers GVB (Sela-Abramovich et al, 2008). Two
important modifiers of guanylate cyclase are nitric oxide (soluble form;
Denninger et al, 1999) and atrial natriuretic peptide (membrane-bound
form; Waldman and Murad, 1989), and a vast literature indicates that
each may play an important role in modulating oocyte cGMP levels and
meiotic arrest (reviewed by Zhang et al, 2007).
Two recent papers have solidified the importance of cGMP in
meiotic regulation in mouse oocytes. In the first, Norris et al (2009),
using FRET-based cyclic nucleotide sensors, provided convincing
evidence that oocyte cAMP levels are maintained by granulosa cell
cGMP that is transmitted through gap junctions to suppress oocyte
PDE3A activity; further, follicular LH stimulation suppresses cGMP
production by the granulosa cells, leading to a decrease in oocyte
cGMP and meiotic resumption. In the second study, Vaccari et al
(2009) report a number of important findings: (1) the cGMP-specific
PDE, PDE5, is preferentially expressed in the granulosa compartment;
(2) cGMP suppresses cAMP hydrolysis in oocyte extracts; (3) LH
stimulation of cultured follicles leads to reduced oocyte cGMP before
GVB that requires mediation by EGF-like peptides (see below) and is
prevented by PDE5 inhibitors; and (4) microinjection of cGMP-specific
PDE into oocytes overcomes meiotic arrest in PDE3A-dependent
fashion. These data therefore provide convincing evidence that meiotic
arrest depends, at least in part, on cGMP supplied by the granulosa
compartment that reaches the oocyte through gap junctions to restrict
PDE3A activity and maintain elevated oocyte cAMP.

IV. Mechanisms of Meiotic Induction
cAMP plays an important role in maintaining the prophase I
arrest in oocytes, but this cyclic nucleotide has a dual role in meiotic
regulation, since it also mediates the meiosis-inducing action of
gonadotropin in granulosa cells. Dekel (1988) proposed an explanation
for such a paradox in that maturation is blocked when oocyte cAMP is
maintained above an inhibitory threshold but that meiotic resumption
results from a transient pulse of elevated cAMP within the granulosa
cells. Indeed, transient pulsing of follicles or CEOs with cAMP analogs
or cAMP-elevating agents triggers meiotic resumption (Tsafriri et al,
1972; Hillensjo et al, 1978; Dekel et al, 1981; Downs et al, 1988).
Although it has been known for many years that the preovulatory
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surge of gonadotropins is the initial stimulus for meiotic resumption in
vivo (Lindner et al, 1974; Tsafriri et al, 1982), only recently have
some of the downstream transduction pathways mediating
gonadotropin action been uncovered.

Mitogen-Activated Protein Kinase
Mitogen-activated protein kinase (MAPK), known also as
extracellular-regulated kinase (ERK), comprises a family of Ser/Thr
kinases that are optimally activated upon phosphorylation on threonine
and tyrosine residues (Seger and Krebs, 1995; Chen et al, 2001). They
are turned on by phosphorylation signal cascades initiated by a
panoply of external signals and transduction pathways. Two isoforms
are expressed in mammalian oocytes, ERK1 and ERK2, that are
actively engaged in meiotic regulation. Activity is controlled by the
upstream kinase, MEK, which, in turn, is regulated further upstream in
vertebrate oocytes by the MEK kinase, MOS, a product of the cmos
protooncogene (Sagata et al, 1988). On the other hand, somatic cell
MEK is regulated by Raf isoforms (Chen et al, 2001).
Perturbation of these two upstream regulatory sites has
profound effects on meiotic progression that implicate ERK1/2 in the
mechanisms regulating oocyte maturation. Because upstream
regulation of ERKs by MOS is unique to the oocyte, eliminating MOS by
knockout or other means prevents activation of ERK specifically in the
germ cell, thereby allowing analysis of germ cell-specific functions. In
oocytes from Mos knockout mice, meiotic maturation progresses
normally but oocytes fail to block in MII, demonstrating an essential
role for ERKs in mediating this second check point (Colledge et al,
1994; Hashimoto et al, 1994). ERK activity is unaltered and MPF
fluctuates normally during maturation up until MII, when MPF activity
drops prematurely (Araki et al, 1996; Choi et al, 1996; Verlhac et al,
1996).
Important tools that have emerged for elucidating ERK
participation in oocyte maturation are the MEK inhibitors, PD98059
and U0126 (Alessi et al, 1995; Dudley et al, 1995; Favata et al, 1998;
Davies et al, 2000). These agents have been shown to prevent ERK
stimulation and meiotic induction in isolated mouse cumulus cellenclosed oocytes (Leonardsen et al, 2000; Su et al, 2001, 2002) or
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follicles (Su et al, 2003). Similar results were obtained in the rat (SelaAbramovich et al, 2005; Motola et al, 2008) and numerous non-rodent
mammalian species (reviewed by Fan and Sun, 2004); yet these
inhibitors have little effect on spontaneous maturation (Fan et al,
2003; Tong et al, 2003).
Oocyte ERK1/2 activity is not required for GVB in rodent
oocytes, since activity increases only after GVB, whether maturation
occurs spontaneously (Verlhac et al, 1993; Lu et al, 2001; Tan et al,
2001) or is hormonally-induced (Su et al, 2002; Sela-Abramovich et
al, 2005). This relationship is not as clear in domestic species, since
ERK1/2 is activated prior to GVB in spontaneously maturing equine,
porcine and bovine oocytes (Fissore et al, 1996; Goudet et al, 1998;
Inoue et al, 1998). That ERK activity within the rodent oocyte is not
necessary for meiotic resumption is supported by the finding that in
mouse oocytes lacking MOS, FSH-induced maturation in hypoxanthinearrested cumulus cell-enclosed oocytes was not compromised;
nevertheless, U0126 suppressed meiotic induction in granulosa cellcoupled oocytes (Su et al, 2002). These results suggest that
cumulus/mural granulosa cell ERK is necessary for the in vitro
induction of maturation by agents acting through the somatic
compartment. Consistent with this is the finding that cumulus cell
ERK1/2 activation, as assessed by western analysis of its
phosphorylation status, precedes GVB in meiotically induced oocytes
(Su et al, 2002). However, in the mouse, oocyte paracrine signaling is
absolutely required for the cumulus cell ERK1/2 response and meiotic
induction, demonstrating that the oocyte plays a crucial role in
regulating its own meiotic maturation (Su et al, 2003).
Until recently, the conclusion that granulosa cell ERK stimulation
mediated hormone-induced oocyte maturation was based primarily on
two important criteria: (1) granulosa cell ERK activity increased prior
to GVB and (2) MEK inhibitors suppressed both this activity and
meiotic resumption. Although PD98059 and U0126 are relatively
specific kinase inhibitors (Davies et al, 2000; Bain et al, 2007), a
question of specificity in mouse oocytes was recently raised. Both MEK
inhibitors prevented meiotic induction in cumulus-free mouse oocytes
induced to resume maturation even though such induction was not
mediated by an increase in ERK1/2 activity; the inhibitors were equally
effective in similarly treated Mos−/− oocytes (LaRosa and Downs,
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2005). This study, therefore, demonstrated a direct inhibitory effect of
MEK inhibitors on the oocyte by means unrelated to ERK1/2 activation
and rendered somewhat tenuous earlier conclusions drawn concerning
ERK1/2 involvement in meiotic induction.
However, a new study by JoAnne Richards’ lab (Fan et al, 2009)
has put to rest any doubt regarding the importance of ERK1/2 in
meiotic induction. Since two isoforms of ERK exist in the oocyte,
knocking out both was essential to determine unequivocally whether
the kinase is required for meiotic induction. And since Erk2-null mice
are embryonic lethal (Aouadi et al, 2006), ERK2 function could not be
eliminated at the organism level. The authors accomplished the double
knockout through conditional ablation of ERK2 function in granulosa
cells by crossing Erk2fl/fl mice with Cyp19-Cre transgenic mice, which
knocks out ERK2 activity in granulosa cells, and then crossing these F1
mice into the Erk1−/− background. Activation of ERK1/2 in the
granulosa cells that normally occurs following LH stimulation was
thereby completely eliminated, and, as a consequence, a myriad of
post-LH ovulatory follicular responses was prevented, including meiotic
resumption, cumulus expansion, ovulation and luteinization, while
FSH-dependent effects on follicle growth were extended (Fan et al,
2009). These results show the critical role Erk1/2 plays in the
preovulatory response to LH, but, most relevant to this review,
demonstrate the absolute requirement for Erk1/2 in meiotic induction,
at least in the mouse.

EGF-like peptides
In 1985, Dekel and Sherizly demonstrated stimulation of GVB in
cultured rat preovulatory follicles by epidermal growth factor (EGF),
and a similar action in cultured mouse CEOs was confirmed three years
later (Downs et al, 1988). Moreover, EGF proved to be the most potent
of ten growth factors tested for stimulation of meiotic induction and
cumulus expansion (Downs, 1989). In the next several years, studies
by Roy and Greenwald (1990; 1991a,b) suggested a link between
gonadotropin stimulation of granulosa cells and EGF-mediated events:
(1) FSH-stimulated DNA synthesis was mimicked by cAMP and EGF;
(2) FSH triggered EGF synthesis; and (3) FSH-stimulated DNA
synthesis was blocked by EGF antiserum. Numerous labs subsequently
demonstrated a meiosis-inducing action by members of the EGF
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growth factor family (eg, Brucker et al, 1991; Das et al, 1992; Goud et
al, 1998;Tsafriri et al, 1989; Prochazka et al, 2000), but more than a
decade passed before expression of EGF-like peptides by mural and
cumulus granulosa cells in response to gonadotropin stimulation was
reported (Espey and Richards, 2002; Sekiguchi et al, 2004; Park et al,
2004; Ashkenazi et al, 2005; Ben-Ami et al, 2006).
A seminal study by Conti and colleagues (Park et al, 2004)
determined that the preovulatory actions of LH are, indeed, mediated
by members of the EGF growth factor family--not by EGF, but by
amphiregulin and epiregulin, and, to a lesser extent beta-cellulin. This
study also showed that these peptides act through the granulosa cells,
where they bind to the EGF receptor (Shimada et al, 2006).
Subsequent studies confirmed the potent meiosis-inducing action of
these EGF-like peptides on the somatic compartment to stimulate GVB
(reviewed by Hsieh et al, 2009) and that knockout of EGF-like peptides
in mice compromised meiotic resumption (Hsieh et al, 2007). In
addition, it appears that protein kinase C (PKC) mediates, at least in
part, the increase in EGF-like peptides in cumulus granulosa cells in
response to gonadotropin stimulation (Downs and Chen, 2008; Chen
et al, 2008), consistent with a stimulatory action of PKC activators on
meiotic resumption (reviewed by Downs et al, 2001). Romero and
Smitz (2009) recently reported that optimal induction of meiotic
resumption in cultured mouse follicles by epiregulin required hCG, but
these experiments were conducted in follicles grown in vitro that were
not exposed to hormonal priming in vivo, which may affect their
responsiveness (cf, Fujinaga et al, 1994).
Shimada et al (2006) carried out an extensive analysis of the
dynamics of EGF-like peptides during the preovulatory period and
proposed an elaborate signaling cascade in which EGF-like peptides
and prostaglandin E2 provide paracrine communication between the
mural and cumulus granulosa cells as well as autocrine stimulation
among each individual granulosa cell sub-type. Gonadotropin or mural
granulosa-derived PGE2 elicits expression of EGF-like peptides in the
cumulus mass by a p38MAPK-dependent process that act in autocrine
fashion to trigger ERK1/2-dependent gene transcription. These gene
products then mediate the actions of gonadotropins on oocyte
maturation, cumulus expansion and ovulation (Shimada et al, 2006;
Conti et al, 2006).
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Gap junction regulation
The gap junctional coupling pathway is an important conduit
through which regulatory molecules are exchanged between the
follicular somatic and germ cell compartments, and this interface
between cumulus cells and the oocyte is intimately linked to meiotic
regulation (Carabatsos et al, 2000). While it is generally agreed that
this coupling pathway plays a critical role in maintaining meiotic arrest,
there is less of a consensus on how gap junction dynamics relate to
meiotic resumption. More than thirty years ago, the attractive
hypothesis was proffered that gonadotropin stimulation terminated
coupling between the oocyte and granulosa cell compartments,
thereby preventing the transfer of inhibitory molecules (eg, cAMP) to
the oocyte and triggering GVB (Gilula et al,1978; Dekel and Beers,
1978). Since that time, considerable evidence has been generated to
support this idea. Ultrastructural studies revealed that significant
alteration of gap junctions occurred at the time of GVB (Larsen et al,
1986, 1987) or commitment to undergo GVB (Racowsky et al, 1989;
Wert and Larsen, 1990). Racowsky and Baldwin (1989) showed that
when the cumulus cell-enclosed oocyte was physically separated from
the mural granulosa cell wall in the intact hamster preovulatory follicle,
meiotic arrest was compromised. GVB can also be initiated by chemical
interruption of the coupling pathway in rat follicles (Piontkewitz and
Dekel, 1993; Sela-Abramovich et al, 2006) or arrested mouse CEOs
(Downs, 2001). Furthermore, gonadotropin stimulation causes a rapid
phosphorylation of Cx43 (Lau et al, 1992; Granot and Dekel, 1994;
Shimada et al, 2001; Kalma et al, 2004; Sela-Abramovich et al, 2005,
2006) that is associated with gap junction closure and appears to be
dependent on EGF-like peptides (Lau et al, 1992; Leithe and Rivedal,
2004).
A critical issue regarding gap junction involvement in meiotic
regulation, in addition to when, is where the uncoupling occurs. There
are two likely sites where uncoupling could elicit a meiotic response:
the mural/cumulus granulosa interface and the cumulus/oocyte
interface (See Fig. 4). Although several studies have shown a decrease
in metabolic or dye coupling between the oocyte and cumulus cells at
the time of GVB, others showed that the coupling does not significantly
decline prior to GVB (reviewed by Downs, 1995). Furthermore,
coupling inhibitors can block the meiosis-promoting action of
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gonadotropin (Fagbohun and Downs, 1991; Coskun and Lin, 1994;
Downs, 2001) or cumulus cells Vozzi et al, 2001) in isolated CEOs,
indicating a need for patent gap junctions in meiotic induction.
However, since in the latter model system the oocyte is not coupled to
the mural granulosa component of the follicle and requires inhibitory
agents to maintain meiotic arrest, it may not accurately reflect
conditions in situ. Furthermore, uncoupling the cumulus mass from the
mural granulosa could bring about GVB by terminating the flow of
inhibitory molecules to the oocyte despite extant communication with
the cumulus cells (Larsen et al, 1987).
With this question in mind, Norris et al, (2008) examined gap
junction closure in cultured mouse follicles, using two-photon
microscopy to monitor diffusion of a microinjected gap junction
permeant tracer. They reported that, following LH exposure, gap
junction permeability within the mural granulosa decreased prior to
GVB in association with ERK1/2-dependent phosphorylation of Cx43,
but the oocyte was not uncoupled from the cumulus mass before
meiotic resumption. Antibody to Cx43 and gap junction inhibitor both
blocked coupling and stimulated GVB. Thus, the data support the
conclusion that LH triggers GVB in the follicle by sequestering the
oocyte-cumulus cell mass from the rest of the follicle, thereby
preventing gap junction-mediated inhibitory input from the mural
granulosa cells such as cGMP (Norris et al, 2008, 2009). Nevertheless,
although the data convincingly support such a mechanism, they do not
prove it is the primary means by which LH works in this capacity in
vivo. Indeed, treatment of LH-stimulated follicles with a low dose of
the ERK1/2 inhibitor, U0126, prevented gap junction closure but had
no effect on meiotic induction (Norris et al, 2008). This supports the
alternative possibility that a positive stimulus mediates hormoneinduced maturation as opposed to simply isolating the oocyte from the
somatic compartment (cf, Downs et al, 1988). Recent evidence from
the porcine system also suggests that meiotic resumption does not
result simply from loss of gap junctional communication (Sasseville et
al, 2009).
The mural/cumulus isolation mechanism also fails to take into
account the role of EGF-like peptides in meiotic resumption. The rapid
expression of these peptides following gonadotropin stimulation and
their potent meiosis-inducing action on the cumulus-enclosed oocyte
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are commensurate with a paracrine action of mural granulosa-derived
peptides that diffuse to the CEO and stimulate GVB and cumulus
expansion (Shimada et al, 2006; Panigone et al, 2008). ERK1/2
appears to mediate actions of the EGF-like peptides but to also have
functions upstream of EGFR activation. Preventing activation of EGFR
blocks--but only partially--ERK1/2 activation, yet meiotic induction in
mouse follicles is prevented (Panigone et al, 2008). Thus, under these
conditions, coupling between the cumulus and mural granulosa
compartments may be abolished (cf, Norris et al, 2008), but meiotic
induction cannot occur in the absence of EGFR activation. Hence,
although the oocyte may be isolated from a major source of inhibitory
input (eg, cGMP), this may not be the sole mechanism regulating
meiotic resumption; rather, a positive stimulus for maturation
triggered by EGF-like peptides in the CEO is implicated (Fig. 4).

Propagating the signal from cumulus to oocyte
At this time, the nature of the putative positive signal is very
much a matter of conjecture. Numerous laboratories have investigated
the possibility of a diffusible meiotic inducer of granulosa origin by
coculturing meiotically arrested oocytes with granulosa cells under a
variety of conditions. Studies have shown that cocultured cells can
alter the medium in such a way that DO are stimulated to resume
maturation; this has been interpreted as due to active secretion of a
diffusible factor that can act on the oocyte to trigger a meiotic
response (reviewed by Downs et al, 2006). But we have been unable
to consistently demonstrate this effect to a degree that would support
such a mechanism in vivo. Confounding interpretation are several
caveats inherent in these types of experiments that include the use of
small medium volumes, oil overlays, and oocytes denuded of their
granulosa cell investment. In some instances, the positive coculture
effect observed may be explained by somatic cell-mediated alterations
in the levels of culture medium components such as energy substrates
and meiotic inhibitors like hypoxanthine (Downs et al, 2006). It should
be noted, however, that the transzonal cumulus cell processes that
traverse the zona pellucida to make contact with the oolemma are
ideally suited for depositing secreted products in close proximity to the
oocyte, which would make possible oocyte exposure to high
concentrations of a paracrine factor at these focal points (Albertini et
al, 2001). Such a mechanism is difficult to test experimentally.
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One type of paracrine factor that has garnered considerable
scrutiny in the last decade are two closely related sterols, termed
meiosis-activating sterol (MAS), derived from follicular fluid and bull
testicular tissue, that were shown to stimulate meiotic resumption in
hypoxanthine-arrested mouse oocytes (Byskov et al, 1995). Since
then, many studies have confirmed a meiosis-inducing action in a
variety of species and have reported other beneficial effects on
development; nevertheless, the accumulated data have failed to
identify MAS as an obligatory mediator of meiotic resumption, and its
role in this capacity has been seriously challenged (Tsafriri et al,
2005). Steroids are a second type of paracrine factor suggested as a
meiosis-inducing agent within the follicle. Despite earlier reports to the
contrary, a recent reexamination of this question has generated data
supporting a meiosis-inducing action of androgens on arrested mouse
oocytes in vitro (reviewed by Deng et al, 2009). However we have
been unable to duplicate these results in the mouse (Downs,
unpublished), and Tsafriri and colleagues have been unsuccessful in
rats, leading to the conclusion that these compounds are not
obligatory mediators of meiotic induction in vivo (Tsafriri and Motola,
2007). Although androgens can induce meiosis in fish and frogs and
certain mammalian species, particularly the pig, Li et al (2009)
speculate that throughout evolution androgens have become
increasingly less important for this function and have been replaced by
gonadotropins.
As mentioned earlier, numerous studies using chemical gap
junctional blockers have implicated this coupling pathway in the
hormone induction within CEO in vitro. Nevertheless, the chemical
nature of the putative positive agent that can traverse the cumulusoocyte gap junctions remains enigmatic. One appealing candidate,
calcium, can induce meiotic resumption (Homa et al, 1993), and
calcium or a calcium-releasing agent has been shown to cross these
gap junctions (Mattioli et al, 1998; Webb et al, 2002). Evidence is
strongest in the spontaneously maturing mouse oocyte model, where
the involvement of PKC and the PI3 kinase signaling pathway have
been implicated (Lefevre et al, 2007). However, calcium does not
appear to be the agent responsible for transducing the maturation
signal generated by gonadotropin stimulation (Webb et al, 2002b;
Mehlmann et al, 2006). Clearly, if gap junction-mediated transfer of a
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positive stimulus is important for meiotic induction, the agent in
question needs to be identified.
Whatever the positive signal received by the mouse oocyte,
cGMP-sensitive PDE3A likely mediates its action. The drop in oocyte
cGMP that occurs prior to GVB would release an inhibition on the
enzyme, increasing its activity. But it has also been shown that protein
kinase B/Akt stimulates meiotic resumption in mouse oocytes in a
PDE3A-dependent manner (Han et al, 2006). Thus, the putative
positive signal may act by turning on the PI3 transduction pathway,
activating Akt and PDE3A, and thereby driving GVB. It is possible that
a fall in cGMP acts cooperatively with Akt activation to rapidly trigger
cAMP degradation.
It is also possible that a transient rise in cAMP within the oocyte
could stimulate increased PDE3A activity. We recently found that cAMP
levels in mouse oocytes from primed mice injected with an ovulatory
dose of hCG were significantly elevated 1 h post-hCG (Chen and
Downs, unpublished), well before meiosis was reinitiated. This
observation is consistent with our study in which pulsing immature
denuded mouse oocytes with high concentrations of cAMP produced a
meiosis-inducing stimulus in inhibitor-containing medium (Chen et al,
2009). Although PDE activity was not measured, the results support
the possibility that the enzyme can be activated by high oocyte cAMP
levels, since (1) cAMP falls rapidly thereafter in vivo prior to GVB and
(2) AMP-activated protein kinase is activated in oocytes pulsed with
cAMP in vitro (see section below).

IV. AMP-Activated Protein Kinase and Meiotic
Resumption
It is generally accepted that negative regulation of meiotic
maturation by cAMP occurs via stimulation of PKA; thus, it follows that
increased PDE3A activity leads to a drop in oocyte cAMP levels and
subsequent GVB principally through inactivation of PKA. However, PDE
cleaves cAMP into 5′-AMP, a compound that has been largely ignored
in oocyte physiology, presumed to be an inactive byproduct of the
enzyme in oocytes. Yet 5′-AMP is an important regulator of a
serine/threonine kinase termed AMP-activated protein kinase, or

Molecular Reproduction and Development, Vol. 77, No. 7 (July 2010): pg. 566-585. DOI. This article is © Wiley and
permission has been granted for this version to appear in e-Publications@Marquette. Wiley does not grant permission
for this article to be further copied/distributed or hosted elsewhere without the express permission from Wiley.

25

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

AMPK, that has been implicated in the regulation of meiotic induction
in mouse oocytes.
AMPK is a member of the AMPK/SNF1 protein kinase family
whose members can be found in a diverse array of organisms (eg,
mammals, plants and yeast) and are typically activated in response to
nutritional or environmental stress. AMPK controls the activity of
important rate-limiting enzymes of carbohydrate and fat metabolism,
acting as a type of “fuel gauge” in response to changes in cellular
energy charge (Hardie et al, 2006). Thus, as a result of stresses that
compromise cellular energy levels, AMPK becomes activated, and a
principal function is to conserve energy by shutting down energydepleting pathways and activating energy-generating pathways (Fig.
5A). These activities are controlled at the level of post-translational
modification and also gene transcription (Hardie, 2003).

Figure 5 AMPK in metabolism and oocyte maturation. A, general metabolic control.
High levels of ATP suppress AMPK activity while elevated AMP has the opposite effect.
Activation of AMPK (asterisk) suppresses anabolic pathways that consume ATP and
stimulates catabolic pathways that generate ATP. B, proposed contribution of AMPK to
meiotic resumption in the mouse oocyte. PKA can phosphorylate AMPK and maintain it
in the inactive state. A number of different stimuli can activate AMPK, including stress,
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AMP produced by cAMP degradation, conversion of AICAR to the AMP analog, ZMP, and
upstream kinases such as LKB1 and CaMKKβ. Active AMPK phosphorylates, and
inactivates, mitochondria-associated acetyl CoA carboxylase II. This enzyme catalyzes
the conversion of acetyl CoA to malonyl CoA, an important negative regulator of fatty
acid transport into the mitochondrion, and, thus, fatty acid oxidation. Since fatty acid
oxidation appears to be a vital component of meiotic induction in mouse oocytes, the
positive action of AMPK on oocyte maturation is likely due, at least in part, to
activation of fatty acid oxidation (see Downs et al, 2009),

AMPK is a heterotrimeric protein with a catalytic α subunit and β
and γ regulatory subunits, and its activity is sensitively controlled
within cells by the AMP/ATP ratio (reviewed by Sanz, 2009). Since the
level of ATP in cells is in the millimolar range while that of AMP is much
lower, small increases in AMP or larger decreases in ATP significantly
increase the AMP/ATP ratio and bring about activation of the enzyme
(Hardie et al, 1998). AMP activates AMPK allosterically but also by
promoting phosphorylation of its catalytic α subunit at T172 by an
upstream kinase and suppressing its inactivation by dephosphorylation
(Hardie and Carling, 1997; Sanders et al, 2007). AMPKα can also be
negatively regulated at S485/491 by elevated cAMP, presumably via
PKA (Hurley et al, 2006), and suppressing AMPK activity could help
mediate meiotic arrest brought about by high levels of cAMP in the
oocyte. AMP does not accumulate appreciably in cells due to the
activity of adenylate kinase, but it is possible that, after the
gonadotropin surge, PDE activity within oocytes generates enough AMP
from cAMP degradation to activate AMPK that, in turn, can provoke a
positive stimulus for oocyte maturation.
We have shown that both α1 and α2 isoforms of the catalytic
subunit of AMPK are present in extracts from oocytes and oocytecumulus cell complexes (Downs et al, 2002). Also, the AMPK activator,
AICAR, is a potent stimulator of GVB, and this meiotic induction is
associated with increased AMPK activity. AICAR is unable to reverse
the inhibitory action of MPF inhibitors, indicating a site of action
upstream of MPF. Subsequent studies have established that an
increase in AMPK precedes GVB and is required for meiotic induction
by AICAR (Chen et al, 2006), different stresses (LaRosa and Downs,
2006, 2007) and the more physiological stimulators, FSH and
amphiregulin (Chen et al, 2008); furthermore, specific AMPK inhibitors
can prevent such meiotic induction. Interestingly, recent work from
our lab shows that cAMP pulsing of the oocyte itself can also induce
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maturation, in concert with activation of AMPK (Chen et al, 2009),
supporting the idea that PDE-generated AMP can activate AMPK. AMPK
may act by turning on fatty acid oxidation, which appears to be
important for meiotic resumption in the mouse (Downs et al, 2009).
Although the accumulated data support a role for AMPK in meiotic
induction in the mouse, it remains to be determined if its participation
is an absolute requirement. A potential scheme is presented in Fig. 5B
that shows how AMPK might participate in meiotic resumption in
mouse oocytes.
Work from other labs suggests that the meiosis-inducing action
of AMPK may be unique to the mouse. When cow and pig oocytes were
treated with AMPK activators, meiotic maturation was suppressed
instead of stimulated (Bilodeau-Geoseels et al, 2007; Mayes et al,
2007; Tosca et al, 2007). In addition, work in progress in our lab
comparing mouse and rat oocytes indicates profound differences in a
number of meiotic behaviors, most notably a failure of rat oocyte
AMPK to stimulate meiotic resumption and differences in localization of
active AMPK throughout the maturation period from GVB to MII.
The participation of AMPK in reproduction is an important
consideration, especially considering its potential relationship with
certain reproductive complications. A common treatment for both
polycystic ovary syndrome and type II diabetes is metformin, a drug
that has recently been shown to act through activation of AMPK (Zhou
et al, 2001). Thus, it is possible that alterations in AMPK function can
lead to reproductive anomalies and this kinase holds promise as a
potential therapeutic target (eg, Ruderman and Prentki, 2004; Kahn et
al, 2005; Viollet et al, 2009; Zhang et al, 2009). Indeed, recent use of
a diabetic mouse model has shown that AMPK can ameliorate some of
the symptoms of diabetes, including lesions in normal meiotic
maturation (Ratchford et al, 2007).
An additional regulatory role for AMPK that has recently been
uncovered is that of mitotic cell polarity and division (Williams and
Brenman, 2008) that has important implications for the malignant
phenotype (Kuhajda, 2008; Jansen et al, 2009). Current work in
progress in our lab shows that active AMPK localizes with condensed
chromatin and the meiotic spindle throughout maturation; thus, it is
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likely that this kinase plays an important role throughout the entire
period of oocyte maturation, from meiotic resumption to MII.

V. Concluding remarks
The recent work on EGF-like peptides and cGMP serve to
emphasize the complex and highly integrated nature of meiotic
regulation. Carefully timed paracrine and gap junctional signaling
between the mural and cumulus granulosa cells as well as between the
somatic and germ cell compartments is essential for the successful
control of oocyte development from early growth through terminal
maturation prior to fertilization. This complexity is inherent in the
challenge to those studying the process.
Figure 1 incorporates results from recent studies into an
integrated scheme for meiotic regulation in the mouse follicle. It is not
meant to be all-inclusive, and emphasis is on those aspects for which a
reasonable body of evidence exists in the litereature. Since not all
potential chemical and pathway participants could be discussed in this
review due to space constraints, this diagram should be viewed as a
simplified version of reality. Certain aspects are speculative and
remain to be proven, but with the rapid advances in molecular and
technical tools in recent years, the rate of important new findings can
only accelerate. Some important unanswered questions remain,
including: (1) How are signal transduction pathways integrated
between the somatic and germ cell compartments to communicate the
meiosis-inducing signal? (2) To what extent are gap junction
uncoupling and positive stimulation utilized to achieve meiotic
resumption? (3) What is the chemical nature of the putative positive
stimulus? and (4) What differences exist between species in meiotic
regulation?
It is becoming increasingly clear that what occurs
mechanistically in one species is not necessarily duplicated in another.
It is already known that significant differences exist between species in
the sensitivity of oocytes to meiotic inhibitors, the timing of meiotic
maturation, and even maturation status at the time of ovulation. While
we know that LH is the initial upstream positive regulator of GVB, and
MPF is the downstream meiotic trigger, the intermediate
hormonal/metabolic/biochemical activity manifested in granulosa cells
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and oocytes to reach that physiological endpoint may exhibit
considerable variation between species. It therefore remains
incumbent upon us to resist sweeping generalizations based on data
from a limited number of species. Because of this, it is possible, if not
likely, that no oocyte from a given species mimics completely the
transduction systems implemented by another species.

Figure 6

Model for meiotic regulation in the mouse. Shown are the three cell types

within the follicle--mural and cumulus granulosa cells and the oocyte—and the
interactions between them. Red lines depict inhibitory processes; green lines are
stimulatory; and dotted lines represent agents that diffuse between cells. Active
enzymes within the oocyte are denoted by an asterisk. In the oocyte, PGR3-dependent
cAMP production activates PKA, which negatively regulates MPF. cGMP produced within
the granulosa cells by soluble or membrane bound guanylate cyclase (GC) is
transmitted through gap junctions to the oocyte where it suppresses PDE3 activity and
helps to maintain meiotic arrest by sustaining high cAMP levels and PKA activity.
Soluble GC can be stimulated by nitric oxide (NO), while membrane-bound GC can be
stimulated by atrial natriuretic peptide (ANP). LH stimulation of the mural granulosa
cells initiates a signal transduction cascade that results in p38MAPK-dependent
production of EGF-like peptides (EGFp) that act in autocrine fashion to stimulate the
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phosphorylation and activation of ERK1/2. ERK1/2 then drives the synthesis of
prostaglandin E2 that diffuses to cumulus granulosa cells, binds to the prostaglandin
receptor PTGER2 and triggers the synthesis of EGFp (see Shimada et al, 2006). FSH
can mimic this action in cumulus cells. ERK1/2 terminates gap junction coupling
between the two granulosa compartments and blocks cGMP transfer to the oocyte; it
also generates a positive signal (X) for maturation that can be transmitted through
gap junctions or possibly diffuses to the oocyte. PDE3 activity in the oocyte is
increased via protein kinase B (Akt), the removal of cGMP inhibition, and perhaps also
by a transient increase in oocyte cAMP and PKA activity that occurs following
gonadotropin stimulation of the granulosa cells. The resulting decrease in cAMP levels
leads to inactivation of PKA and elimination of its block to MPF activation. AMPK is
activated in immature mouse oocytes in response to gonadotropin stimulation and
helps drive MPF activation and GVB, most likely through indirect means. Its activation
may result from AMP generated by PDE3 and/or perhaps by an upstream kinase
(AMPKK), whose identity has not yet been identified.
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